Market Overview

EndoStim (NASDAQ: STIM)

21.27 +2.85 (15.47%)

Analyst Ratings

DateResearch FirmActionCurrentPT
1/22/21William BlairUpgradesOutperform
10/26/20Canaccord GenuityMaintainsBuy8.0
10/06/20BTIGReiteratesBuy10.0
4/09/20Canaccord GenuityMaintainsBuy4.0
11/06/19JMP SecuritiesMaintainsMarket Outperform12.0
8/15/18JMP SecuritiesMaintainsMarket Outperform40.0
8/15/18Canaccord GenuityMaintainsBuy36.0
7/24/18Canaccord GenuityInitiates Coverage OnBuy33.0
7/23/18William BlairInitiates Coverage OnOutperform
7/23/18JMP SecuritiesInitiates Coverage OnMarket Outperform36.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter